Journal
JOURNAL OF TOXICOLOGICAL SCIENCES
Volume 34, Issue 2, Pages 191-200Publisher
JAPANESE SOC TOXICOLOGICAL SCIENCES
DOI: 10.2131/jts.34.191
Keywords
Selenium; Selenoamino acid; Methylselenocysteine; ICP-MS; Speciation; Stable isotope
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology, Japan [19390033, 19790103]
- Grants-in-Aid for Scientific Research [19790103] Funding Source: KAKEN
Ask authors/readers for more resources
Se-Methylselenocysteine (MeSeCys) is not only a selenium (Se) supplement but also a more promising precursor of an anti-tumor drug containing Se than selenomethionine, which is Currently used as Se supplement. In this study, the metabolism of MeSeCys labeled with an Se isotope, Se-82, in rats depleted of endogenous natural abundance isotopes with another Se isotope, Se-78, was traced for 21 days when MeSeCys was continuously and perorally ingested at a supplemental dose. The tracer experiment was performed with our improved method that utilized an inductively coupled plasma-deuterium reaction-mass spectrometer. The substitution of endogenous Se with a single isotope, 78Se, facilitated the detection of exogenous labeled Se. Exogenous Se in the form of MeSeCys preferably accumulated and/or assimilated in the liver, kidneys and testes with long-term ingestion of MeSeCys and was utilized for the synthesis of selenoproteins, i.e., extracellular and cellular glutathione peroxidases and selenoprotein P. Meanwhile, intact MeSeCys was not excreted into urine although trimethylselenonium was detected in addition to selenosugar. The results suggest that MeSeCys was transformed into selenide via methylselenol by beta-lyase. Consequently, it is surmised that MeSeCys is a precursor of methylselenol under long-term ingestion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available